Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $669.53 | 38 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $106.36 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $101.07 | 5 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $86.51 | 4 | $0 (2024) |
| QOL Medical, LLC | $74.44 | 4 | $0 (2022) |
| Braintree Laboratories, Inc. | $55.58 | 3 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $39.66 | 3 | $0 (2023) |
| Ardelyx, Inc. | $20.00 | 1 | $0 (2023) |
| Synergy Pharmaceuticals Inc | $19.96 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $19.80 | 1 | $0 (2022) |
| Takeda Pharmaceuticals America, Inc. | $19.05 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $134.51 | 8 | Takeda Pharmaceuticals U.S.A., Inc. ($38.10) |
| 2023 | $158.11 | 8 | INTERCEPT PHARMACEUTICALS, INC. ($44.29) |
| 2022 | $236.03 | 13 | Takeda Pharmaceuticals U.S.A., Inc. ($62.97) |
| 2021 | $65.16 | 4 | AbbVie Inc. ($47.35) |
| 2019 | $20.07 | 1 | AbbVie, Inc. ($20.07) |
| 2018 | $19.96 | 1 | Synergy Pharmaceuticals Inc ($19.96) |
| 2017 | $35.69 | 3 | Takeda Pharmaceuticals America, Inc. ($19.05) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/13/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/01/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Rare Disease | ||||||
| 05/14/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: GI COLON PREP | ||||||
| 05/03/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Immunology | ||||||
| 03/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/23/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/14/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2023 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Biosimilars | ||||||
| 05/30/2023 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: GI COLON PREP | ||||||
| 04/25/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/28/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 02/27/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Gastroenterology | ||||||
| 02/09/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/17/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/06/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/25/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/27/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/13/2022 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/07/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Gastroenterology | ||||||
| 08/30/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/02/2022 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $16.36 | General |
| Category: THERAPY FOR CSID | ||||||
| 06/29/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Gastroenterology | ||||||
| 04/21/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: GI COLON PREP | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 337 | 337 | $681,339 | $37,110 |
| 2022 | 5 | 374 | 378 | $608,513 | $42,113 |
| 2021 | 6 | 250 | 255 | $557,707 | $32,563 |
| 2020 | 6 | 193 | 204 | $474,696 | $26,473 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 129 | 129 | $267,082 | $13,686 | 5.1% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 71 | 71 | $181,283 | $9,163 | 5.1% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 46 | 46 | $93,743 | $4,504 | 4.8% |
| 00142 | Anesthesia for lens surgery | Facility | 2023 | 45 | 45 | $62,161 | $4,204 | 6.8% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 34 | 34 | $41,602 | $3,473 | 8.3% |
| 00103 | Anesthesia for procedure on eyelid | Facility | 2023 | 12 | 12 | $35,469 | $2,080 | 5.9% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 149 | 150 | $252,633 | $15,725 | 6.2% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2022 | 62 | 62 | $146,995 | $8,670 | 5.9% |
| 00142 | Anesthesia for lens surgery | Facility | 2022 | 72 | 75 | $67,928 | $7,553 | 11.1% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 53 | 53 | $95,246 | $6,010 | 6.3% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 38 | 38 | $45,711 | $4,156 | 9.1% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2021 | 64 | 64 | $147,605 | $9,087 | 6.2% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 69 | 69 | $128,739 | $7,342 | 5.7% |
| 00103 | Anesthesia for procedure on eyelid | Facility | 2021 | 35 | 35 | $123,987 | $6,654 | 5.4% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 36 | 36 | $68,501 | $4,153 | 6.1% |
| 00142 | Anesthesia for lens surgery | Facility | 2021 | 22 | 27 | $53,662 | $2,747 | 5.1% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 24 | 24 | $35,212 | $2,580 | 7.3% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2020 | 51 | 51 | $111,846 | $5,915 | 5.3% |
| 00103 | Anesthesia for procedure on eyelid | Facility | 2020 | 25 | 28 | $97,713 | $5,528 | 5.7% |
| 00142 | Anesthesia for lens surgery | Facility | 2020 | 45 | 52 | $97,220 | $5,510 | 5.7% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2020 | 36 | 37 | $98,155 | $5,191 | 5.3% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 18 | 18 | $39,380 | $2,194 | 5.6% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2020 | 18 | 18 | $30,383 | $2,136 | 7.0% |
About Dr. Mary Mcallister, MD
Dr. Mary Mcallister, MD is a Anesthesiology healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790723989.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Mcallister, MD has received a total of $669.53 in payments from pharmaceutical and medical device companies, with $134.51 received in 2024. These payments were reported across 38 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($669.53).
As a Medicare-enrolled provider, Mcallister has provided services to 1,154 Medicare beneficiaries, totaling 1,174 services with total Medicare billing of $138,259. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Location Annapolis, MD
- Active Since 06/02/2006
- Last Updated 09/16/2009
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1790723989
Products in Payments
- OCALIVA (Drug) $86.51
- ENTYVIO (Biological) $84.32
- SUCRAID (Drug) $74.44
- LINZESS (Drug) $64.94
- SUTAB (Drug) $55.58
- TRULANCE (Drug) $25.96
- VIBERZI (Drug) $21.35
- Creon (Drug) $20.07
- IBSRELA (Drug) $20.00
- Trulance (Drug) $19.96
- DUPIXENT (Biological) $19.80
- Amitiza (Drug) $19.05
- IDACIO (Biological) $18.16
- GIVLAARI (Drug) $17.91
- OMVOH (Drug) $17.58
- EOHILIA (Drug) $16.75
- INFLECTRA (Biological) $16.64
- DIFICID (Drug) $15.54
- Talicia (Drug) $14.02
- XIFAXAN (Drug) $13.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Annapolis
Dr. David Levy, Md, MD
Anesthesiology — Payments: $1,121
Dr. Sohail Zaidi, Md, MD
Anesthesiology — Payments: $1,114
Dr. Kelly O'donnell, Md, MD
Anesthesiology — Payments: $839.39
Paul Crawford, Md, MD
Anesthesiology — Payments: $502.22
Richard Ro, M.d, M.D
Anesthesiology — Payments: $489.45
Dr. Sunil Patel, Md, MD
Anesthesiology — Payments: $445.09